Connecta Therapeutics
The Dierssen lab is centered on understanding cognition and behavior and their how they are perturbed in intellectual disability. Her lab uses this knowledge to discover new therapeutic targets. Dr. Dierssen has published more than 150 papers, with an h-index of 43 and major research papers in the upper 10% impact factor journals on her field, in international peer reviewed journals and 20 book chapters.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Connecta Therapeutics
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.